Form 8-K - Current report:
SEC Accession No. 0001493152-24-042252
Filing Date
2024-10-23
Accepted
2024-10-23 17:00:19
Documents
13
Period of Report
2024-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32875
  Complete submission text file 0001493152-24-042252.txt   204426

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE orgs-20241023.xsd EX-101.SCH 3018
3 XBRL LABEL FILE orgs-20241023_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE orgs-20241023_pre.xml EX-101.PRE 24167
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3427
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 241389721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)